Adamas to Present at Two Upcoming Investor Conferences
Gregory T. Went, Ph.D., the company’s Founder, Chairman and Chief Executive Officer, is scheduled to present at the Cowen and Company38th Annual Health Care Conferenceon Monday, March 12, 2018at 3:30 p.m. ET Richard A. King, the company’s Chief Operating Officer, is scheduled to present at the 17th Annual Needham Healthcare Conferenceon Tuesday, March 27, 2018at 9:00 a.m. ET
The presentations will be webcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events.cfm. Archived versions of the webcasts will be available via replay for 30 days following the presentations.
Adamas is using its deep understanding of time-dependent biology to redefine the treatment experience for patients suffering from chronic neurological diseases. The company is building upon the commercial launch of GOCOVRI™ (amantadine) extended release capsules (previously ADS-5102), the first and only
Continuum Health Communications
Director, Corporate Communications & Investor Relations
Source: Adamas Pharmaceuticals, Inc.